Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00479791 · ClinicalTrials.gov registry record · NA

Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids

A NA study of Type 2 Diabetes Mellitus, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT00479791 is a NA study of Type 2 Diabetes Mellitus that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 11 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00479791, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

A meal rich in very-long chain omega-3 fatty acids or oleic acid may lower postprandial insulin levels in comparison to a meal rich in linoleic acid or palmitic acid. A meal rich in very long-chain omega-3 fatty acids may lower postprandial triglyceride levels compared to other fatty acids.

Conditions Studied

Interventions

  • BEHAVIORAL Test meals rich in different fatty acids

Study Locations (1)

Texas

  • UT Southwestern Medical Center at Dallas - Dallas

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 1997-04
Est. Completion 1999-06
Phase NA

What the Registry Record Tells You About NCT00479791

The ClinicalTrials.gov registry entry for NCT00479791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Test meals rich in different fatty acids is the first listed.

NCT00479791 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00479791 about?

NCT00479791 is a clinical study titled "Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids". A meal rich in very-long chain omega-3 fatty acids or oleic acid may lower postprandial insulin levels in comparison to a meal rich in linoleic acid or palmitic acid. A meal rich in very long-chain omega-3 fatty acids may lower postprandial triglyceride levels compared to other fatty acids.

What is the current status of trial NCT00479791?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 1997-04. Estimated completion is 1999-06.

What conditions does trial NCT00479791 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT00479791?

The interventions under investigation include: Test meals rich in different fatty acids (BEHAVIORAL).

Who is sponsoring clinical trial NCT00479791?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00479791 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.